Secukinumab and Bimekizumab for Hidradenitis Suppurativa
Вставка
- Опубліковано 9 чер 2024
- Check out the full article on HCPLive: www.hcplive.com/view/secukinu...
Patients with HS are getting a long-awaited influx of targeted therapies. Jennifer L. Hsiao, MD, discusses their immediate impact. - Наука та технологія